Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sema4 Holdings Corp (NQ: SMFR ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Jan 9, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sema4 Holdings Corp < Previous 1 2 3 4 5 Next > Sema4 Holdings Corp. (NASDAQ: SMFR) Long Term Shareholder Notice: Investigation of Potential Wrongdoing February 08, 2023 San Diego, CA -- (SBWIRE) -- 02/08/2023 -- An investigation was announced for current long-term investors in shares of Sema4 Holdings Corp. (NASDAQ: SMFR) concerning potential breaches of fiduciary... Via SBWire Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 09, 2023 Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash. Via Benzinga Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance January 09, 2023 From GeneDx Holdings Corp. Via GlobeNewswire Sema4 Holdings's Return on Invested Capital Overview December 26, 2022 Via Benzinga What To Know About Goldman Sachs's Downgrade of Sema4 Holdings December 07, 2022 Via Benzinga Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference December 30, 2022 Sema4|GeneDx President & Chief Executive Officer, Katherine Stueland, to deliver presentation From Sema4 Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday December 29, 2022 On Thursday, 116 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Monday December 12, 2022 Monday saw 196 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday December 09, 2022 On Friday, 127 companies set new 52-week lows. Via Benzinga ConocoPhillips To Rally Over 30%? Here Are 10 Other Price Target Changes For Wednesday December 07, 2022 Barclays raised ConocoPhillips (NYSE: COP) price target from $135 to $151. Barclays analyst Jeanine Wai maintained an Overweight rating on the stock. ConocoPhillips shares fell 3.2% to close at $115.61... Via Benzinga New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU December 05, 2022 Data underscores the value of mitochondrial DNA testing and the opportunity to improve health outcomes for critically ill newborns with early medical intervention From Sema4 Via GlobeNewswire Sema4 Reports Third Quarter 2022 Financial Results and New Strategic Direction November 14, 2022 From Sema4 Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday December 02, 2022 On Friday, 72 companies hit new 52-week lows. Via Benzinga NASDAQ:SMFR Investor Alert: Deadline on November 7, 2022 in Lawsuit Against Sema4 Holdings Corp. November 09, 2022 San Diego, CA -- (SBWIRE) -- 11/09/2022 -- The Shareholders Foundation announced that a deadline is coming up on November 7, 2022 in the lawsuit filed for certain investors of Sema4 Holdings Corp.... Via SBWire Deadline Alert: Sema4 Holdings Corp. (SMFR, SMFRW) Class Action - Bronstein, Gewirtz & Grossman, LLC, A Prominent Firm, Encourages Shareholders of Last Few Hours to Actively Participate November 07, 2022 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Stocks That Hit 52-Week Lows On Wednesday November 30, 2022 During Wednesday's session, 107 stocks hit new 52-week lows. Via Benzinga Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday November 17, 2022 Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday November 16, 2022 On Wednesday, 70 companies set new 52-week lows. Via Benzinga SMFR FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Sema4 Holdings Corp. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SMFR, SMFRW November 07, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Earnings Scheduled For November 14, 2022 November 14, 2022 Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. Via Benzinga Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bed Bath & Beyond, Sema4, Medtronic, and Palantir and Encourages Investors to Contact the Firm November 06, 2022 From Bragar Eagel & Squire Via GlobeNewswire SMFR FINAL DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Sema4 Holdings Corp. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SMFR, SMFRW November 06, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal SEMA4 HOLDINGS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Sema4 Holdings Corp. - SMFR November 04, 2022 From Kahn Swick & Foti, LLC Via Business Wire Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022 November 04, 2022 From Sema4 Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kohl’s, Bed Bath & Beyond, Sema4, and Medtronic and Encourages Investors to Contact the Firm October 31, 2022 From Bragar Eagel & Squire Via GlobeNewswire Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies October 31, 2022 Guideline adoption can help end the diagnostic odyssey experienced by many families From Sema4 Via GlobeNewswire ROSEN, A TOP RANKED FIRM, Encourages Sema4 Holdings Corp. Investors With Losses Over $100K to Secure Counsel Before Important November 7 Deadline in Securities Class Action - SMFR, SMFRW October 29, 2022 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns October 27, 2022 From Sema4 Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kohl’s, Bed Bath & Beyond, Sema4, and Medtronic and Encourages Investors to Contact the Firm October 26, 2022 From Bragar Eagel & Squire Via GlobeNewswire Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels October 26, 2022 Exome and genome tests report 30% fewer inconclusive results and a higher diagnostic yield compared to multi-gene panel tests; research to be presented at American Society of Human Genetics Annual... From Sema4 Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.